2.63
-0.07 (-2.59%)
| Previous Close | 2.70 |
| Open | 2.65 |
| Volume | 2,398 |
| Avg. Volume (3M) | 2,583 |
| Market Cap | 10,970,151 |
| Price / Sales | 0.310 |
| Price / Book | 4.05 |
| 52 Weeks Range | |
| Earnings Date | 5 May 2025 - 9 May 2025 |
| Profit Margin | -27.22% |
| Operating Margin (TTM) | -29.58% |
| Diluted EPS (TTM) | -2.27 |
| Quarterly Revenue Growth (YOY) | 0.90% |
| Total Debt/Equity (MRQ) | 614.35% |
| Current Ratio (MRQ) | 1.05 |
| Levered Free Cash Flow (TTM) | 1.80 M |
| Return on Assets (TTM) | -7.60% |
| Return on Equity (TTM) | -151.23% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Bearish | Mixed |
| Medical Devices (Global) | Bearish | Mixed | |
| Stock | Strata Skin Sciences, Inc. | Bearish | Bearish |
AIStockmoo Score
| Analyst Consensus | 1.5 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | -1.0 |
| Technical Oscillators | -2.5 |
| Average | -0.38 |
|
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United states. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Value |
| % Held by Insiders | 5.48% |
| % Held by Institutions | 64.08% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Azzad Asset Management Inc /Adv | 31 Mar 2025 | 11,000 |
| Financial Perspectives, Inc | 31 Mar 2025 | 101 |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |